Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN614774 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Fms-Related tyrosine Kinase 3 (FLT3) antibody (PE)
- Antibody type
- Monoclonal
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Yellow dye
- Isotype
- IgG
- Antibody clone number
- BV10A4
- Vial size
- 100 tests
- Storage
- 4°C
- Handling
- DO NOT FREEZE! This product is photosensitive and should be protected from light.
Submitted references Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease.
Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells.
Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand.
Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.
Whartenby KA, Calabresi PA, McCadden E, Nguyen B, Kardian D, Wang T, Mosse C, Pardoll DM, Small D
Proceedings of the National Academy of Sciences of the United States of America 2005 Nov 15;102(46):16741-6
Proceedings of the National Academy of Sciences of the United States of America 2005 Nov 15;102(46):16741-6
Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F, Kern W, Schoch C, Kohlmann A, Hiddemann W, Haferlach T, Schnittger S
Haematologica 2005 Dec;90(12):1617-25
Haematologica 2005 Dec;90(12):1617-25
Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells.
Christensen JL, Weissman IL
Proceedings of the National Academy of Sciences of the United States of America 2001 Dec 4;98(25):14541-6
Proceedings of the National Academy of Sciences of the United States of America 2001 Dec 4;98(25):14541-6
Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand.
Haylock DN, Horsfall MJ, Dowse TL, Ramshaw HS, Niutta S, Protopsaltis S, Peng L, Burrell C, Rappold I, Buhring HJ, Simmons PJ
Blood 1997 Sep 15;90(6):2260-72
Blood 1997 Sep 15;90(6):2260-72
Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.
Rappold I, Ziegler BL, Köhler I, Marchetto S, Rosnet O, Birnbaum D, Simmons PJ, Zannettino AC, Hill B, Neu S, Knapp W, Alitalo R, Alitalo K, Ullrich A, Kanz L, Bühring HJ
Blood 1997 Jul 1;90(1):111-25
Blood 1997 Jul 1;90(1):111-25
No comments: Submit comment
No validations: Submit validation data